Parabilis CEO Mathai Mammen on biotech's record IPO

Mathai Mammen, Parabilis Medicines CEO June 10, 2026 01:24 PM EDT DealsIPOs 'Go­ing for our own moon­shot': Para­bilis CEO on biotech's record IPO Kyle LaHucik Biotech Correspondent Para­bilis Med­i­cines ce­ment­ed the largest biotech IPO in in­dus­try his­to­ry on Wednes­day with its $670 mil­lion de­but on the Nas­daq. But the Cam­bridge, MA-based drug … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER